ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Clearmind Medicine, Inc.
1.16
-0.5400
-31.76%
盤後:
1.19
0.0300
+2.59%
19:59 EDT
成交量:
1,551.24萬
成交額:
2,892.20萬
市值:
172.32萬
市盈率:
-0.01
高:
1.56
開:
1.50
低:
1.16
收:
1.70
52周最高:
524.00
52周最低:
1.16
股本:
148.56萬
流通股本:
147.60萬
量比:
72.32
換手率:
1051.01%
股息:
- -
股息率:
- -
每股收益(TTM):
-175.9200
每股收益(LYR):
-303.4772
淨資產收益率:
-114.61%
總資產收益率:
-51.35%
市淨率:
0.15
市盈率(LYR):
0.00
資料載入中...
總覽
公司
新聞
公告
Clearmind Medicine簽署最終協議,收購自動泊車與機器人出租車無線充電公司51%股權
美股速递
·
09/04
Clearmind重大里程碑達成:Cmnd-100酒精使用障礙IIa期試驗啓動,C部分入組已達三分之一
美股速递
·
09/01
美國聯邦對迷幻創新支持升温,Clearmind推進MDMA-N-酰乙醇胺治療PTSD知識產權佈局
美股速递
·
08/24
Clearmind Medicine 簽署意向書,擬收購自動泊車系統電動汽車無線充電解決方案公司51%控股權
美股速递
·
08/03
Clearmind宣佈CMND-100安全性積極成果:FDA監管臨床試驗A部分全程劑量遞增均顯示良好耐受性
美股速递
·
07/30
Clearmind Medicine公布其基於迷幻藥的神經塑形劑Meai鼻內製劑積極保留率結果
美股速递
·
07/16
Clearmind Medicine 就美國「大美復甦倡議」中的成癮治療創新徵詢信息作出回應
美股速递
·
07/10
Clearmind Medicine達成重大里程碑,完成FDA監管I/II期試驗A部分治療
美股速递
·
06/22
Clearmind Medicine將在「Inside Meai」網絡研討會上展示Cmnd-100迷幻藥臨床研究新發現
美股速递
·
06/05
Clearmind Medicine宣佈約翰霍普金斯IRB批准推進CMND-100 I/II期臨床試驗進入後續階段
美股速递
·
05/26
Clearmind Medicine簽署協議,研究Meai與替爾泊肽聯用及序貫療法,挑戰GLP-1重磅藥物
美股速递
·
05/18
Clearmind Medicine首席執行官Adi Zuloff-Shani博士獲任華盛頓迷幻藥政策聯邦峯會代表
美股速递
·
05/15
Clearmind Medicine達成重要臨床里程碑:其用於酒精使用障礙的藥物CMND-100 I/Iia期試驗現已有20名受試者接受治療
美股速递
·
05/12
Clearmind Medicine宣佈舉辦「Inside MEAI」網絡研討會,分享CMND-100迷幻藥臨床試驗新見解
美股速递
·
05/11
Clearmind Medicine提交新型迷幻化合物治療創傷後應激障礙歐洲專利申請
美股速递
·
05/05
Clearmind Medicine Inc旗下Cmnd-100最高劑量展現卓越安全性,未出現嚴重不良事件
美股速递
·
04/20
Clearmind Medicine公布積極頂線安全性結果:CMND-100專有迷幻療法達到酒精使用障礙試驗主要終點
美股速递
·
04/20
Clearmind Medicine公布CMND-100臨床試驗獲數據安全監查委員會積極建議
美股速递
·
04/15
Clearmind Medicine公布第三隊列研究結果:CMND-100安全性優異,未出現嚴重不良事件
美股速递
·
04/14
Clearmind Medicine Inc 啓動CMND-100 I/Iia期臨床試驗,評估其安全性、耐受性、藥代動力學及初步療效
美股速递
·
04/14
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www-web.itiger.com/hant/stock/CMND/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CMND","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CMND\",,,,,undefined,":{"symbol":"CMND","market":"US","secType":"STK","nameCN":"Clearmind Medicine, Inc.","latestPrice":1.16,"timestamp":1788552000000,"preClose":1.7,"halted":0,"volume":15512447,"hourTrading":{"tag":"盘后","latestPrice":1.19,"preClose":1.16,"latestTime":"19:59 EDT","volume":302367,"amount":365529.2841,"timestamp":1788566394845,"change":0.03,"changeRate":0.025862,"amplitude":0.137931},"delay":0,"changeRate":-0.31764705882352945,"floatShares":1475956,"shares":1485551,"eps":-175.92,"marketStatus":"勞工日休市","change":-0.54,"latestTime":"09-04 16:00:00 EDT","open":1.495,"high":1.555,"low":1.16,"amount":28921966.1861367,"amplitude":0.232353,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-175.92,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1788854400000},"marketStatusCode":7,"adr":0,"listingDate":1668142800000,"exchange":"NASDAQ","adjPreClose":1.7,"preHourTrading":{"tag":"盘前","latestPrice":1.5,"preClose":1.7,"latestTime":"09:29 EDT","volume":7111987,"amount":14124734.044600701,"timestamp":1788528599442,"change":-0.2,"changeRate":-0.117647,"amplitude":0.494118},"postHourTrading":{"tag":"盘后","latestPrice":1.19,"preClose":1.16,"latestTime":"19:59 EDT","volume":302367,"amount":365529.2841,"timestamp":1788566394845,"change":0.03,"changeRate":0.025862,"amplitude":0.137931},"volumeRatio":72.31788647599103},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CMND\",,,,,undefined,":{"symbol":"CMND","floatShares":1475956,"roa":"-51.35%","roe":"-114.61%","lyrEps":-303.47721,"volumeRatio":72.31788647599103,"shares":1485551,"dividePrice":0,"high":1.555,"amplitude":0.232353,"preClose":1.7,"low":1.16,"week52Low":1.16,"pbRate":"0.15","week52High":524,"institutionHeld":0,"latestPrice":1.16,"eps":-175.92,"divideRate":0,"volume":15512447,"delay":0,"ttmEps":-175.92,"open":1.495,"prevYearClose":18.1,"prevWeekClose":1.16,"prevMonthClose":1.94,"prevQuarterClose":2.2,"fiveDayClose":1.76,"twentyDayClose":1.63,"sixtyDayClose":3.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CMND\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-21","symbol":"CMND","defaultRemindTime":1779370200000,"type":"split","dateTimestamp":1779336000000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"US","date":"2025-12-15","symbol":"CMND","defaultRemindTime":1765809000000,"type":"split","dateTimestamp":1765774800000,"forFactor":40,"toFactor":1,"ratio":40},{"market":"US","date":"2023-11-28","symbol":"CMND","defaultRemindTime":1701181800000,"type":"split","dateTimestamp":1701147600000,"forFactor":30,"toFactor":1,"ratio":30}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CMND\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CMND\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CMND\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CMND","date":"2026-09-04","current":-0.006594,"percent":0.942041,"low":-78.674359,"twenty":-1.471776,"median":-0.899997,"eighty":-0.463679,"high":-0.132425,"avg":-3.132471,"sd":9.113474,"marketCap":2525436},"quantilePoints":[{"date":"2021-09-10","current":-70.893378,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":24346632.12},{"date":"2021-09-17","current":-71.757932,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":24430331.48},{"date":"2021-09-24","current":-73.487039,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":25125635.9},{"date":"2021-10-01","current":-18.935815,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":24276713.03},{"date":"2021-10-08","current":-18.012117,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":23471549.77},{"date":"2021-10-15","current":-18.012117,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":23660527.38},{"date":"2021-10-22","current":-17.781192,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":23366442.66},{"date":"2021-10-29","current":-16.626569,"twenty":-61.834695,"median":-19.430851,"eighty":-5.327909,"marketCap":21791515.03},{"date":"2021-11-05","current":-17.319343,"twenty":-61.834695,"median":-18.935815,"eighty":-5.327909,"marketCap":22614497.39},{"date":"2021-11-12","current":-16.16472,"twenty":-61.834695,"median":-18.473966,"eighty":-5.327909,"marketCap":20907283.62},{"date":"2021-11-19","current":-15.933796,"twenty":-61.834695,"median":-18.243042,"eighty":-5.327909,"marketCap":20493935.46},{"date":"2021-11-26","current":-17.319343,"twenty":-61.834695,"median":-18.243042,"eighty":-5.327909,"marketCap":22007930.87},{"date":"2021-12-03","current":-16.16472,"twenty":-61.834695,"median":-18.012117,"eighty":-5.327909,"marketCap":20516830.56},{"date":"2021-12-10","current":-15.933796,"twenty":-61.834695,"median":-18.012117,"eighty":-5.327909,"marketCap":20363701.64},{"date":"2021-12-17","current":-14.548248,"twenty":-61.834695,"median":-18.012117,"eighty":-5.327909,"marketCap":18448575.82},{"date":"2021-12-23","current":-13.393625,"twenty":-61.834695,"median":-17.781192,"eighty":-5.327909,"marketCap":16986524.41},{"date":"2021-12-31","current":-13.393625,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":17198471.74},{"date":"2022-01-07","current":-12.700852,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":16298591.95},{"date":"2022-01-14","current":-12.239002,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":15851627.15},{"date":"2022-01-21","current":-10.853455,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":14077636.85},{"date":"2022-01-28","current":-12.931776,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":16468260.15},{"date":"2022-02-04","current":-14.548248,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":18518085.11},{"date":"2022-02-11","current":-14.317323,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":18343985.21},{"date":"2022-02-18","current":-14.317323,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":18253458.39},{"date":"2022-02-25","current":-13.393625,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":17082383.51},{"date":"2022-03-04","current":-4.943147,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":14402278.55},{"date":"2022-03-11","current":-4.741385,"twenty":-61.834695,"median":-17.615217,"eighty":-5.327909,"marketCap":13870054.34},{"date":"2022-03-18","current":-4.489184,"twenty":-61.834695,"median":-17.582743,"eighty":-5.327909,"marketCap":13226105.9},{"date":"2022-03-25","current":-2.663476,"twenty":-61.834695,"median":-17.550268,"eighty":-5.327909,"marketCap":12172123.95},{"date":"2022-04-01","current":-2.696359,"twenty":-61.834695,"median":-17.319343,"eighty":-5.327909,"marketCap":12315499.88},{"date":"2022-04-08","current":-3.090948,"twenty":-61.834695,"median":-17.319343,"eighty":-5.327909,"marketCap":14024131.41},{"date":"2022-04-14","current":-2.433299,"twenty":-61.834695,"median":-17.088418,"eighty":-5.327909,"marketCap":11016821.23},{"date":"2022-04-22","current":-2.30177,"twenty":-61.834695,"median":-16.857494,"eighty":-5.327909,"marketCap":10351738.45},{"date":"2022-04-29","current":-2.564829,"twenty":-61.834695,"median":-16.857494,"eighty":-5.327909,"marketCap":11431112.19},{"date":"2022-05-06","current":-2.531947,"twenty":-61.834695,"median":-16.511107,"eighty":-5.327909,"marketCap":11240443.79},{"date":"2022-05-13","current":-2.433299,"twenty":-61.834695,"median":-16.16472,"eighty":-5.327909,"marketCap":10747956.2},{"date":"2022-05-20","current":-2.466182,"twenty":-61.834695,"median":-16.16472,"eighty":-5.327909,"marketCap":10972362.04},{"date":"2022-05-27","current":-2.334652,"twenty":-61.834695,"median":-16.16472,"eighty":-5.327909,"marketCap":10462796.86},{"date":"2022-06-03","current":-2.400417,"twenty":-61.834695,"median":-15.933796,"eighty":-5.327909,"marketCap":10896966.45},{"date":"2022-06-10","current":-2.30177,"twenty":-61.834695,"median":-15.702871,"eighty":-5.327909,"marketCap":10273199.15},{"date":"2022-06-17","current":-2.400417,"twenty":-61.834695,"median":-15.471947,"eighty":-5.327909,"marketCap":10503138.41},{"date":"2022-06-24","current":-2.367534,"twenty":-61.744414,"median":-15.471947,"eighty":-5.327909,"marketCap":10469452.66},{"date":"2022-07-01","current":-1.560974,"twenty":-60.553176,"median":-15.147663,"eighty":-5.327909,"marketCap":10729626.02},{"date":"2022-07-08","current":-1.560974,"twenty":-57.232721,"median":-15.147663,"eighty":-5.327909,"marketCap":10710469.08},{"date":"2022-07-15","current":-1.605574,"twenty":-57.232721,"median":-15.147663,"eighty":-5.327909,"marketCap":10950633.46},{"date":"2022-07-22","current":-1.516375,"twenty":-57.130437,"median":-15.147663,"eighty":-5.327909,"marketCap":10468944.81},{"date":"2022-07-29","current":-1.427176,"twenty":-56.195971,"median":-15.147663,"eighty":-5.327909,"marketCap":9885259.74},{"date":"2022-08-05","current":-1.471776,"twenty":-55.226088,"median":-14.779173,"eighty":-5.327909,"marketCap":10092669.27},{"date":"2022-08-12","current":-1.427176,"twenty":-54.0772,"median":-14.548248,"eighty":-5.327909,"marketCap":9901792.86},{"date":"2022-08-19","current":-1.427176,"twenty":-43.677709,"median":-14.317323,"eighty":-5.327909,"marketCap":9745576.64},{"date":"2022-08-26","current":-1.382577,"twenty":-41.597849,"median":-14.317323,"eighty":-5.327909,"marketCap":9442770.76},{"date":"2022-09-02","current":-1.271079,"twenty":-41.597849,"median":-14.086399,"eighty":-5.327909,"marketCap":8615042.98},{"date":"2022-09-09","current":-1.427176,"twenty":-41.597849,"median":-14.086399,"eighty":-5.135307,"marketCap":9711214.67},{"date":"2022-09-16","current":-1.360278,"twenty":-41.597849,"median":-13.855475,"eighty":-5.135307,"marketCap":9096403.07},{"date":"2022-09-23","current":-1.248779,"twenty":-41.597849,"median":-13.62455,"eighty":-5.135307,"marketCap":8172150.47},{"date":"2022-09-30","current":-0.929266,"twenty":-41.597849,"median":-13.393625,"eighty":-5.135307,"marketCap":6512507.37},{"date":"2022-10-07","current":-1.087585,"twenty":-41.597849,"median":-13.393625,"eighty":-5.074202,"marketCap":7646662.48},{"date":"2022-10-14","current":-1.080702,"twenty":-41.597849,"median":-13.393625,"eighty":-5.074202,"marketCap":7496705.29},{"date":"2022-10-21","current":-1.049293,"twenty":-41.597849,"median":-13.278163,"eighty":-5.074202,"marketCap":7357917.44},{"date":"2022-10-28","current":-1.165881,"twenty":-41.597849,"median":-13.162701,"eighty":-5.074202,"marketCap":8234273.61},{"date":"2022-11-04","current":-1.08907,"twenty":-41.597849,"median":-13.162701,"eighty":-5.074202,"marketCap":7753472.39},{"date":"2022-11-11","current":-1.082212,"twenty":-38.270012,"median":-12.931776,"eighty":-5.074202,"marketCap":7833552.75},{"date":"2022-11-18","current":-1.935818,"twenty":-37.438053,"median":-12.700852,"eighty":-5.074202,"marketCap":13927482.09},{"date":"2022-11-25","current":-1.650458,"twenty":-37.438053,"median":-12.585389,"eighty":-5.074202,"marketCap":11873272.72},{"date":"2022-12-02","current":-1.27255,"twenty":-37.438053,"median":-12.008078,"eighty":-5.074202,"marketCap":9091614.07},{"date":"2022-12-09","current":-1.079739,"twenty":-37.438053,"median":-11.682462,"eighty":-4.943147,"marketCap":7625598.02},{"date":"2022-12-16","current":-1.40109,"twenty":-37.438053,"median":-11.587771,"eighty":-4.791826,"marketCap":9845331.19},{"date":"2022-12-23","current":-1.375382,"twenty":-37.438053,"median":-11.587771,"eighty":-4.741294,"marketCap":9740512.57},{"date":"2022-12-30","current":-1.141438,"twenty":-37.438053,"median":-11.587771,"eighty":-4.741294,"marketCap":8114893.38},{"date":"2023-01-06","current":-1.118301,"twenty":-37.438053,"median":-11.587771,"eighty":-4.539624,"marketCap":7989125.08},{"date":"2023-01-13","current":-1.62475,"twenty":-37.438053,"median":-11.587771,"eighty":-4.186477,"marketCap":11656520.47},{"date":"2023-01-20","current":-1.568192,"twenty":-37.438053,"median":-10.853455,"eighty":-4.136102,"marketCap":11253776.1},{"date":"2023-01-27","current":-1.33682,"twenty":-37.438053,"median":-9.227851,"eighty":-4.059359,"marketCap":9661985.46},{"date":"2023-02-03","current":-1.332642,"twenty":-37.438053,"median":-9.227851,"eighty":-4.059359,"marketCap":9371651.68},{"date":"2023-02-10","current":-1.393097,"twenty":-37.438053,"median":-9.227851,"eighty":-4.059359,"marketCap":9812413.93},{"date":"2023-02-17","current":-1.272187,"twenty":-37.438053,"median":-9.227851,"eighty":-4.059359,"marketCap":8867258.2},{"date":"2023-02-24","current":-1.240431,"twenty":-37.438053,"median":-9.227851,"eighty":-4.059359,"marketCap":8572078.87},{"date":"2023-03-03","current":-1.10085,"twenty":-37.438053,"median":-9.227851,"eighty":-3.551938,"marketCap":7606207.65},{"date":"2023-03-10","current":-1.198293,"twenty":-37.438053,"median":-9.227851,"eighty":-3.45974,"marketCap":8185550.86},{"date":"2023-03-17","current":-1.120516,"twenty":-37.438053,"median":-9.227851,"eighty":-2.755547,"marketCap":7980631.72},{"date":"2023-03-24","current":-0.916786,"twenty":-37.438053,"median":-9.227851,"eighty":-2.696359,"marketCap":6519731.67},{"date":"2023-03-31","current":-0.417647,"twenty":-37.438053,"median":-9.227851,"eighty":-2.624017,"marketCap":3018701.27},{"date":"2023-04-06","current":-0.132425,"twenty":-37.438053,"median":-9.227851,"eighty":-2.584558,"marketCap":960449.73},{"date":"2023-04-14","current":-0.500779,"twenty":-37.438053,"median":-9.227851,"eighty":-2.531947,"marketCap":3666478.25},{"date":"2023-04-21","current":-0.622397,"twenty":-37.438053,"median":-9.227851,"eighty":-2.499064,"marketCap":4520895.91},{"date":"2023-04-28","current":-0.579473,"twenty":-37.438053,"median":-9.227851,"eighty":-2.453029,"marketCap":4166925.01},{"date":"2023-05-05","current":-0.550857,"twenty":-37.438053,"median":-9.227851,"eighty":-2.433299,"marketCap":3966371.91},{"date":"2023-05-12","current":-0.558011,"twenty":-37.438053,"median":-9.227851,"eighty":-2.433299,"marketCap":4046484.45},{"date":"2023-05-19","current":-0.572319,"twenty":-37.438053,"median":-9.227851,"eighty":-2.400417,"marketCap":4145445.66},{"date":"2023-05-26","current":-0.58694,"twenty":-37.438053,"median":-9.227851,"eighty":-2.367534,"marketCap":4210059.56},{"date":"2023-06-02","current":-0.550709,"twenty":-37.438053,"median":-9.227851,"eighty":-2.367534,"marketCap":3999105.96},{"date":"2023-06-09","current":-0.514478,"twenty":-34.942175,"median":-9.227851,"eighty":-2.321499,"marketCap":3767591.98},{"date":"2023-06-16","current":-0.531091,"twenty":-33.278257,"median":-9.227851,"eighty":-2.30177,"marketCap":3748293.76},{"date":"2023-06-23","current":-0.458354,"twenty":-33.278257,"median":-9.227851,"eighty":-2.28204,"marketCap":3234938.84},{"date":"2023-06-30","current":-0.478478,"twenty":-30.295333,"median":-9.227851,"eighty":-2.043589,"marketCap":3376966.22},{"date":"2023-07-07","current":-0.436578,"twenty":-26.688751,"median":-9.227851,"eighty":-1.802136,"marketCap":3081249.21},{"date":"2023-07-14","current":-0.436972,"twenty":-26.688751,"median":-8.613576,"eighty":-1.651163,"marketCap":3084034.14},{"date":"2023-07-21","current":-0.43717,"twenty":-26.688751,"median":-8.613576,"eighty":-1.562418,"marketCap":3085429.18},{"date":"2023-07-28","current":-0.458608,"twenty":-26.688751,"median":-8.613576,"eighty":-1.560974,"marketCap":3236727.75},{"date":"2023-08-04","current":-0.483799,"twenty":-26.688751,"median":-8.613576,"eighty":-1.558522,"marketCap":3414522.56},{"date":"2023-08-11","current":-0.383836,"twenty":-26.688751,"median":-6.222948,"eighty":-1.516375,"marketCap":2709008.42},{"date":"2023-08-18","current":-0.372906,"twenty":-26.688751,"median":-5.926622,"eighty":-1.471776,"marketCap":2631871.39},{"date":"2023-08-25","current":-0.39406,"twenty":-26.688751,"median":-5.926622,"eighty":-1.471776,"marketCap":2781166.24},{"date":"2023-09-01","current":-0.447028,"twenty":-26.688751,"median":-5.926622,"eighty":-1.427176,"marketCap":3155002.59},{"date":"2023-09-08","current":-0.442472,"twenty":-19.813329,"median":-5.926622,"eighty":-1.427176,"marketCap":3122844.46},{"date":"2023-09-15","current":-0.187109,"twenty":-19.430851,"median":-5.926622,"eighty":-1.427176,"marketCap":1320569.3},{"date":"2023-09-22","current":-0.388305,"twenty":-19.430851,"median":-5.926622,"eighty":-1.427176,"marketCap":2475737.22},{"date":"2023-09-29","current":-0.315336,"twenty":-19.430851,"median":-5.926622,"eighty":-1.415486,"marketCap":2010507.36},{"date":"2023-10-06","current":-0.365327,"twenty":-19.430851,"median":-5.926622,"eighty":-1.395726,"marketCap":2329231.67},{"date":"2023-10-13","current":-0.367265,"twenty":-19.430851,"median":-5.926622,"eighty":-1.382577,"marketCap":2341589.46},{"date":"2023-10-20","current":-0.334674,"twenty":-19.430851,"median":-5.926622,"eighty":-1.368527,"marketCap":2133796.18},{"date":"2023-10-27","current":-0.290523,"twenty":-19.430851,"median":-5.926622,"eighty":-1.366813,"marketCap":1852300.65},{"date":"2023-11-03","current":-0.316281,"twenty":-19.430851,"median":-5.926622,"eighty":-1.360278,"marketCap":2016523.46},{"date":"2023-11-10","current":-0.325261,"twenty":-19.430851,"median":-5.390754,"eighty":-1.337978,"marketCap":2073784.82},{"date":"2023-11-17","current":-0.300361,"twenty":-19.430851,"median":-5.330934,"eighty":-1.337515,"marketCap":1915028.46},{"date":"2023-11-24","current":-0.302508,"twenty":-19.430851,"median":-5.327909,"eighty":-1.335149,"marketCap":1928712.73},{"date":"2023-12-01","current":-0.350938,"twenty":-19.430851,"median":-5.327909,"eighty":-1.296306,"marketCap":2237493.37},{"date":"2023-12-08","current":-0.980569,"twenty":-19.430851,"median":-5.327909,"eighty":-1.274244,"marketCap":6251864.25},{"date":"2023-12-15","current":-0.736628,"twenty":-19.430851,"median":-5.327909,"eighty":-1.271301,"marketCap":4696557.28},{"date":"2023-12-22","current":-0.812759,"twenty":-19.430851,"median":-5.327909,"eighty":-1.259672,"marketCap":5181946.56},{"date":"2023-12-29","current":-0.682126,"twenty":-19.430851,"median":-5.327909,"eighty":-1.237797,"marketCap":4349066.88},{"date":"2024-01-05","current":-0.630384,"twenty":-19.430851,"median":-5.327909,"eighty":-1.211461,"marketCap":4019166.25},{"date":"2024-01-12","current":-0.436686,"twenty":-19.430851,"median":-5.327909,"eighty":-1.179486,"marketCap":2784200.42},{"date":"2024-01-19","current":-0.561866,"twenty":-19.430851,"median":-5.327909,"eighty":-1.15795,"marketCap":3582314.16},{"date":"2024-01-26","current":-0.716167,"twenty":-19.430851,"median":-5.327909,"eighty":-1.132962,"marketCap":4566100.74},{"date":"2024-02-02","current":-0.652747,"twenty":-19.430851,"median":-5.327909,"eighty":-1.116775,"marketCap":5627224.65},{"date":"2024-02-09","current":-0.504935,"twenty":-19.430851,"median":-5.327909,"eighty":-1.1005,"marketCap":4352964.23},{"date":"2024-02-16","current":-0.519849,"twenty":-19.430851,"median":-5.327909,"eighty":-1.096168,"marketCap":4481532.37},{"date":"2024-02-23","current":-0.672729,"twenty":-18.473966,"median":-5.327909,"eighty":-1.087585,"marketCap":5799482.19},{"date":"2024-03-01","current":-0.54179,"twenty":-18.473966,"median":-5.327909,"eighty":-1.08191,"marketCap":4670679.77},{"date":"2024-03-08","current":-0.505134,"twenty":-18.473966,"median":-5.327909,"eighty":-1.079739,"marketCap":4354677.58},{"date":"2024-03-15","current":-0.435211,"twenty":-18.473966,"median":-5.327909,"eighty":-1.064778,"marketCap":3751886.19},{"date":"2024-03-22","current":-0.499967,"twenty":-18.473966,"median":-5.327909,"eighty":-1.046318,"marketCap":4044318},{"date":"2024-03-28","current":-0.471743,"twenty":-18.473966,"median":-5.327909,"eighty":-0.975962,"marketCap":3816009},{"date":"2024-04-05","current":-0.463679,"twenty":-18.473966,"median":-5.327909,"eighty":-0.890377,"marketCap":3750779},{"date":"2024-04-12","current":-0.516095,"twenty":-18.473966,"median":-5.327909,"eighty":-0.810049,"marketCap":4174780},{"date":"2024-04-19","current":-0.475009,"twenty":-18.473966,"median":-5.327909,"eighty":-0.7392,"marketCap":3842428},{"date":"2024-04-26","current":-0.483839,"twenty":-18.473966,"median":-5.327909,"eighty":-0.711567,"marketCap":3913856},{"date":"2024-05-03","current":-0.471784,"twenty":-18.473966,"median":-5.327909,"eighty":-0.652729,"marketCap":3816336},{"date":"2024-05-10","current":-0.604799,"twenty":-18.473966,"median":-5.327909,"eighty":-0.644215,"marketCap":4892320},{"date":"2024-05-17","current":-0.520127,"twenty":-18.473966,"median":-5.327909,"eighty":-0.61393,"marketCap":4207395},{"date":"2024-05-24","current":-0.453599,"twenty":-18.473966,"median":-5.327909,"eighty":-0.600881,"marketCap":3669240},{"date":"2024-05-31","current":-0.459647,"twenty":-18.473966,"median":-5.327909,"eighty":-0.594105,"marketCap":3718163},{"date":"2024-06-07","current":-0.420053,"twenty":-18.473966,"median":-5.109555,"eighty":-0.586092,"marketCap":3397879},{"date":"2024-06-14","current":-0.435455,"twenty":-18.473966,"median":-5.074202,"eighty":-0.577013,"marketCap":3522470},{"date":"2024-06-21","current":-0.612279,"twenty":-18.473966,"median":-5.074202,"eighty":-0.572319,"marketCap":4237588},{"date":"2024-06-28","current":-0.64098,"twenty":-18.566336,"median":-5.074202,"eighty":-0.570751,"marketCap":4436225},{"date":"2024-07-05","current":-0.727082,"twenty":-18.566336,"median":-5.074202,"eighty":-0.570751,"marketCap":5032136},{"date":"2024-07-12","current":-0.770133,"twenty":-18.566336,"median":-5.074202,"eighty":-0.570751,"marketCap":5330091},{"date":"2024-07-15","current":-0.813184,"twenty":-18.566336,"median":-5.074202,"eighty":-0.570751,"marketCap":5628047},{"date":"2024-08-02","current":-0.717515,"twenty":-19.331844,"median":-5.074202,"eighty":-0.562464,"marketCap":4965924},{"date":"2024-08-09","current":-0.569229,"twenty":-19.331844,"median":-5.074202,"eighty":-0.562464,"marketCap":3939633},{"date":"2024-08-16","current":-0.545311,"twenty":-19.331844,"median":-5.074202,"eighty":-0.558549,"marketCap":3774102},{"date":"2024-08-23","current":-0.660114,"twenty":-19.331844,"median":-5.008674,"eighty":-0.558011,"marketCap":4568650},{"date":"2024-08-30","current":-0.631413,"twenty":-19.331844,"median":-4.791826,"eighty":-0.558011,"marketCap":4370013},{"date":"2024-09-06","current":-0.617063,"twenty":-19.331844,"median":-4.539624,"eighty":-0.558011,"marketCap":4270694},{"date":"2024-09-13","current":-0.631413,"twenty":-19.331844,"median":-4.09773,"eighty":-0.558011,"marketCap":4370013},{"date":"2024-09-20","current":-0.506022,"twenty":-19.331844,"median":-4.059359,"eighty":-0.552636,"marketCap":4270694},{"date":"2024-09-27","current":-0.595973,"twenty":-19.331844,"median":-4.059359,"eighty":-0.550947,"marketCap":5029855},{"date":"2024-10-04","current":-0.595973,"twenty":-19.331844,"median":-4.059359,"eighty":-0.550947,"marketCap":5029855},{"date":"2024-10-11","current":-0.653648,"twenty":-19.331844,"median":-4.04729,"eighty":-0.550947,"marketCap":5516615},{"date":"2024-10-18","current":-0.634423,"twenty":-19.331844,"median":-2.811447,"eighty":-0.550947,"marketCap":5354362},{"date":"2024-10-25","current":-0.74016,"twenty":-19.331844,"median":-2.696359,"eighty":-0.550947,"marketCap":6246755},{"date":"2024-10-31","current":-0.70171,"twenty":-19.331844,"median":-2.614152,"eighty":-0.550947,"marketCap":5922249},{"date":"2024-11-08","current":-0.672873,"twenty":-19.430851,"median":-2.531947,"eighty":-0.550857,"marketCap":5678869},{"date":"2024-11-15","current":-0.706517,"twenty":-19.430851,"median":-2.499064,"eighty":-0.550857,"marketCap":5962812},{"date":"2024-11-22","current":-0.644036,"twenty":-19.430851,"median":-2.433299,"eighty":-0.550857,"marketCap":5435488},{"date":"2024-11-29","current":-0.624811,"twenty":-19.430851,"median":-2.433299,"eighty":-0.550857,"marketCap":5273235},{"date":"2024-12-06","current":-0.639229,"twenty":-19.430851,"median":-2.433299,"eighty":-0.550857,"marketCap":5394925},{"date":"2024-12-13","current":-0.70171,"twenty":-19.430851,"median":-2.400417,"eighty":-0.550857,"marketCap":5922249},{"date":"2024-12-20","current":-0.571942,"twenty":-19.430851,"median":-2.367534,"eighty":-0.550857,"marketCap":4827038},{"date":"2024-12-27","current":-0.749773,"twenty":-19.430851,"median":-2.367534,"eighty":-0.550857,"marketCap":6327882},{"date":"2025-01-03","current":-0.696904,"twenty":-19.430851,"median":-2.30177,"eighty":-0.550857,"marketCap":5881685},{"date":"2025-01-10","current":-0.692098,"twenty":-19.430851,"median":-2.30177,"eighty":-0.550857,"marketCap":5841122},{"date":"2025-01-17","current":-0.730548,"twenty":-19.430851,"median":-2.153798,"eighty":-0.550857,"marketCap":6165629},{"date":"2025-01-24","current":-1.150202,"twenty":-19.430851,"median":-1.874119,"eighty":-0.550857,"marketCap":6043939},{"date":"2025-01-31","current":-1.042129,"twenty":-19.430851,"median":-1.662503,"eighty":-0.550857,"marketCap":5476052},{"date":"2025-02-07","current":-1.160721,"twenty":-19.430851,"median":-1.581046,"eighty":-0.550857,"marketCap":6099215},{"date":"2025-02-14","current":-1.13637,"twenty":-19.430851,"median":-1.560974,"eighty":-0.550857,"marketCap":5971260},{"date":"2025-02-21","current":-1.038967,"twenty":-19.430851,"median":-1.560974,"eighty":-0.550857,"marketCap":5459438},{"date":"2025-02-28","current":-0.990265,"twenty":-19.430851,"median":-1.541199,"eighty":-0.550857,"marketCap":5203526},{"date":"2025-03-07","current":-0.900979,"twenty":-19.430851,"median":-1.471776,"eighty":-0.550857,"marketCap":4734356},{"date":"2025-03-14","current":-0.917213,"twenty":-19.430851,"median":-1.471776,"eighty":-0.550857,"marketCap":4819660},{"date":"2025-03-21","current":-1.211596,"twenty":-19.430851,"median":-1.471776,"eighty":-0.550857,"marketCap":6007699},{"date":"2025-03-28","current":-1.08733,"twenty":-19.430851,"median":-1.427176,"eighty":-0.550857,"marketCap":5391525},{"date":"2025-04-04","current":-1.066619,"twenty":-19.430851,"median":-1.427176,"eighty":-0.550857,"marketCap":5288829},{"date":"2025-04-11","current":-0.966947,"twenty":-19.430851,"median":-1.427176,"eighty":-0.550857,"marketCap":4794606},{"date":"2025-04-17","current":-1.004486,"twenty":-19.430851,"median":-1.424416,"eighty":-0.550857,"marketCap":4980742},{"date":"2025-04-25","current":-1.014841,"twenty":-19.430851,"median":-1.40109,"eighty":-0.550857,"marketCap":5032090},{"date":"2025-05-02","current":-1.056263,"twenty":-19.430851,"median":-1.382577,"eighty":-0.550857,"marketCap":5237481},{"date":"2025-05-09","current":-1.011735,"twenty":-19.430851,"median":-1.375382,"eighty":-0.550857,"marketCap":5016685},{"date":"2025-05-16","current":-1.004486,"twenty":-19.430851,"median":-1.366813,"eighty":-0.550857,"marketCap":4980742},{"date":"2025-05-23","current":-1.035552,"twenty":-19.430851,"median":-1.360278,"eighty":-0.550857,"marketCap":5134786},{"date":"2025-05-30","current":-1.001379,"twenty":-19.430851,"median":-1.337978,"eighty":-0.550857,"marketCap":4965338},{"date":"2025-06-06","current":-0.973316,"twenty":-19.430851,"median":-1.337978,"eighty":-0.550857,"marketCap":4826185},{"date":"2025-06-13","current":-0.909542,"twenty":-19.430851,"median":-1.332642,"eighty":-0.550857,"marketCap":4396917},{"date":"2025-06-20","current":-0.913472,"twenty":-19.430851,"median":-1.295818,"eighty":-0.550857,"marketCap":4415915},{"date":"2025-06-27","current":-0.936415,"twenty":-19.430851,"median":-1.273609,"eighty":-0.550857,"marketCap":4526827},{"date":"2025-07-03","current":-1.168394,"twenty":-19.430851,"median":-1.261673,"eighty":-0.550857,"marketCap":5648264},{"date":"2025-07-11","current":-1.040933,"twenty":-19.430851,"median":-1.240431,"eighty":-0.550857,"marketCap":5032090},{"date":"2025-07-18","current":-1.072798,"twenty":-18.473966,"median":-1.211461,"eighty":-0.550857,"marketCap":5186133},{"date":"2025-07-25","current":-1.094042,"twenty":-18.243042,"median":-1.202815,"eighty":-0.550857,"marketCap":5288829},{"date":"2025-08-01","current":-1.062177,"twenty":-18.012117,"median":-1.178715,"eighty":-0.550857,"marketCap":5134786},{"date":"2025-08-08","current":-1.08342,"twenty":-17.781192,"median":-1.163301,"eighty":-0.550857,"marketCap":5237481},{"date":"2025-08-15","current":-1.08342,"twenty":-17.615217,"median":-1.153532,"eighty":-0.550857,"marketCap":5237481},{"date":"2025-08-22","current":-1.062177,"twenty":-17.615217,"median":-1.142724,"eighty":-0.550857,"marketCap":5134786},{"date":"2025-08-29","current":-1.08342,"twenty":-17.615217,"median":-1.133121,"eighty":-0.550857,"marketCap":5237481},{"date":"2025-09-05","current":-1.083951,"twenty":-17.615217,"median":-1.119324,"eighty":-0.550857,"marketCap":5240049},{"date":"2025-09-12","current":-1.115286,"twenty":-17.615217,"median":-1.118135,"eighty":-0.550857,"marketCap":5391525},{"date":"2025-09-19","current":-1.348445,"twenty":-17.589237,"median":-1.118135,"eighty":-0.550857,"marketCap":5466441},{"date":"2025-09-26","current":-1.429352,"twenty":-17.319343,"median":-1.118135,"eighty":-0.550857,"marketCap":5794427},{"date":"2025-10-03","current":-1.375414,"twenty":-16.996048,"median":-1.118135,"eighty":-0.550857,"marketCap":5575769},{"date":"2025-10-10","current":-1.29626,"twenty":-16.765124,"median":-1.118135,"eighty":-0.550857,"marketCap":5254889},{"date":"2025-10-17","current":-1.277382,"twenty":-16.16472,"median":-1.118135,"eighty":-0.550857,"marketCap":5178359},{"date":"2025-10-24","current":-1.324577,"twenty":-16.16472,"median":-1.118135,"eighty":-0.550857,"marketCap":5369684},{"date":"2025-10-31","current":-1.222905,"twenty":-15.610501,"median":-1.118135,"eighty":-0.550857,"marketCap":4957515},{"date":"2025-11-07","current":-0.999602,"twenty":-14.779173,"median":-1.11003,"eighty":-0.550857,"marketCap":4052272},{"date":"2025-11-14","current":-0.466831,"twenty":-14.455878,"median":-1.100951,"eighty":-0.550765,"marketCap":1892481},{"date":"2025-11-21","current":-0.268071,"twenty":-14.224953,"median":-1.099975,"eighty":-0.546197,"marketCap":1086728},{"date":"2025-11-28","current":-0.24222,"twenty":-14.086399,"median":-1.095371,"eighty":-0.543703,"marketCap":981932},{"date":"2025-12-05","current":-0.673835,"twenty":-13.62455,"median":-1.094042,"eighty":-0.543703,"marketCap":2731651},{"date":"2025-12-12","current":-1.06106,"twenty":-13.393625,"median":-1.088758,"eighty":-0.543703,"marketCap":4301415},{"date":"2025-12-19","current":-0.965609,"twenty":-13.162701,"median":-1.087521,"eighty":-0.543703,"marketCap":3914467},{"date":"2025-12-26","current":-0.84722,"twenty":-13.162701,"median":-1.085641,"eighty":-0.543703,"marketCap":3434532},{"date":"2026-01-02","current":-0.669637,"twenty":-12.700852,"median":-1.08342,"eighty":-0.543703,"marketCap":2714630},{"date":"2026-01-09","current":-0.899015,"twenty":-12.146632,"median":-1.08342,"eighty":-0.543703,"marketCap":3644504},{"date":"2026-01-16","current":-0.973008,"twenty":-11.587771,"median":-1.080702,"eighty":-0.543703,"marketCap":3944463},{"date":"2026-01-23","current":-1.049901,"twenty":-11.587771,"median":-1.079739,"eighty":-0.543703,"marketCap":4049449},{"date":"2026-01-30","current":-0.851586,"twenty":-11.587771,"median":-1.073308,"eighty":-0.543703,"marketCap":3284553},{"date":"2026-02-06","current":-0.563836,"twenty":-8.613576,"median":-1.072243,"eighty":-0.543703,"marketCap":2174704},{"date":"2026-02-13","current":-0.423849,"twenty":-8.613576,"median":-1.066619,"eighty":-0.541026,"marketCap":1634777},{"date":"2026-02-20","current":-0.577021,"twenty":-8.613576,"median":-1.066037,"eighty":-0.537847,"marketCap":2225559},{"date":"2026-02-27","current":-0.53514,"twenty":-8.613576,"median":-1.062177,"eighty":-0.536549,"marketCap":2064026},{"date":"2026-03-06","current":-0.502566,"twenty":-8.613576,"median":-1.05906,"eighty":-0.536549,"marketCap":1938390},{"date":"2026-03-13","current":-0.385627,"twenty":-4.943147,"median":-1.056151,"eighty":-0.53281,"marketCap":1487355},{"date":"2026-03-20","current":-0.206114,"twenty":-4.77165,"median":-1.051024,"eighty":-0.530164,"marketCap":1368585},{"date":"2026-03-27","current":-0.231847,"twenty":-4.428656,"median":-1.04883,"eighty":-0.52897,"marketCap":1539450},{"date":"2026-04-02","current":-0.339748,"twenty":-3.99487,"median":-1.046113,"eighty":-0.523835,"marketCap":2255910},{"date":"2026-04-10","current":-0.377498,"twenty":-2.748971,"median":-1.042127,"eighty":-0.520127,"marketCap":2506567},{"date":"2026-04-17","current":-0.262518,"twenty":-2.696359,"median":-1.040933,"eighty":-0.5179,"marketCap":1743108},{"date":"2026-04-24","current":-0.257359,"twenty":-2.597711,"median":-1.035552,"eighty":-0.514478,"marketCap":1708852},{"date":"2026-05-01","current":-0.224108,"twenty":-2.531947,"median":-1.031531,"eighty":-0.511783,"marketCap":1488065},{"date":"2026-05-08","current":-0.86327,"twenty":-2.485911,"median":-1.024161,"eighty":-0.510296,"marketCap":5732064},{"date":"2026-05-15","current":-0.811243,"twenty":-2.433299,"median":-1.014273,"eighty":-0.510296,"marketCap":5386612},{"date":"2026-05-22","current":-0.377536,"twenty":-2.433299,"median":-1.008005,"eighty":-0.505681,"marketCap":2506821},{"date":"2026-05-29","current":-0.376002,"twenty":-2.400417,"median":-1.004486,"eighty":-0.504039,"marketCap":2496630},{"date":"2026-06-05","current":-0.446598,"twenty":-2.367534,"median":-0.999455,"eighty":-0.499967,"marketCap":2965386},{"date":"2026-06-12","current":-0.51259,"twenty":-2.367534,"median":-0.994596,"eighty":-0.498651,"marketCap":3403570},{"date":"2026-06-18","current":-0.404845,"twenty":-2.321499,"median":-0.991077,"eighty":-0.492739,"marketCap":3199763},{"date":"2026-06-26","current":-0.468013,"twenty":-2.30177,"median":-0.980602,"eighty":-0.49207,"marketCap":3699021},{"date":"2026-07-02","current":-0.432301,"twenty":-2.262311,"median":-0.977044,"eighty":-0.488105,"marketCap":3416767},{"date":"2026-07-10","current":-0.389071,"twenty":-1.976951,"median":-0.969308,"eighty":-0.483839,"marketCap":3075090},{"date":"2026-07-17","current":-0.374035,"twenty":-1.699795,"median":-0.957532,"eighty":-0.482232,"marketCap":2956246},{"date":"2026-07-24","current":-0.312009,"twenty":-1.620915,"median":-0.952708,"eighty":-0.478963,"marketCap":2466014},{"date":"2026-07-31","current":-0.30449,"twenty":-1.560974,"median":-0.941592,"eighty":-0.477791,"marketCap":2406592},{"date":"2026-08-07","current":-0.328925,"twenty":-1.560974,"median":-0.934845,"eighty":-0.474646,"marketCap":2599714},{"date":"2026-08-14","current":-0.347721,"twenty":-1.557909,"median":-0.925121,"eighty":-0.472163,"marketCap":2748269},{"date":"2026-08-21","current":-0.325166,"twenty":-1.516375,"median":-0.919213,"eighty":-0.470511,"marketCap":2570003},{"date":"2026-08-28","current":-0.340202,"twenty":-1.471776,"median":-0.912941,"eighty":-0.467711,"marketCap":2688847},{"date":"2026-09-04","current":-0.319527,"twenty":-1.471776,"median":-0.899997,"eighty":-0.463679,"marketCap":2525436}],"updateTime":1788764244071},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CMND\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1194025159","title":"Clearmind Medicine簽署最終協議,收購自動泊車與機器人出租車無線充電公司51%股權","url":"https://stock-news.laohu8.com/highlight/detail?id=1194025159","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194025159?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 19:33","pubTimestamp":1788521591,"startTime":"0","endTime":"0","summary":"Clearmind Medicine已正式签署一项具有约束力的最终协议,拟收购一家致力于自动泊车及机器人出租车领域无线充电技术公司的控股权——具体比例为51%。此次交易的标的公司专注于为自动泊车系统及自动驾驶出租车提供无线充电解决方案,其技术契合当前智能交通和新能源产业融合的趋势。通过本次收购,Clearmind Medicine有望在快速演进的出行生态中构建起更具纵深的技术组合。协议的完成仍须满足惯常的交割条件,相关进展有待后续公告进一步披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CMND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151205269","title":"Clearmind重大里程碑達成:Cmnd-100酒精使用障礙IIa期試驗啓動,C部分入組已達三分之一","url":"https://stock-news.laohu8.com/highlight/detail?id=1151205269","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151205269?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 19:42","pubTimestamp":1788262929,"startTime":"0","endTime":"0","summary":"Clearmind Medicine, Inc.宣布一项关键进展——其核心候选药物Cmnd-100在酒精使用障碍适应症上的IIa期临床试验已正式启动。与此同时,该试验C部分的患者入组工作顺利推进,目前已完成约三分之一的招募目标。Cmnd-100作为一种创新疗法,旨在从神经机制层面干预酒精依赖,为现有治疗选择有限的患者群体带来新的希望。随着入组持续进行,Clearmind有望在年内获得更多阶段性数据,进一步明确Cmnd-100的临床价值与应用前景。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182416631","title":"美國聯邦對迷幻創新支持升温,Clearmind推進MDMA-N-酰乙醇胺治療PTSD知識產權佈局","url":"https://stock-news.laohu8.com/highlight/detail?id=1182416631","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182416631?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 20:04","pubTimestamp":1787573052,"startTime":"0","endTime":"0","summary":"随着美国联邦层面对迷幻药物创新的支持力度不断增强,Clearmind Medicine正加速推进其MDMA-N-酰乙醇胺知识产权组合,致力于创伤后应激障碍(PTSD)的治疗方案开发。\n这一举措恰逢政策环境日趋宽松之际,监管风向的转变正为迷幻辅助疗法开辟新的发展空间。\nClearmind此番在知识产权领域的布局,不仅是技术层面的突破,更是对PTSD治疗范式的一次深度探索。该公司将目光聚焦于MDMA-N-酰乙醇胺这一化合物类别,意图在这一新兴赛道抢占先机。\n在联邦政府态度逐渐转向的背景下,迷幻创新正迎来前所未有的机遇窗口。Clearmind的战略推进,似乎正踩在政策与市场的共振点上。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174101385","title":"Clearmind Medicine 簽署意向書,擬收購自動泊車系統電動汽車無線充電解決方案公司51%控股權","url":"https://stock-news.laohu8.com/highlight/detail?id=1174101385","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174101385?lang=zh_tw&edition=fundamental","pubTime":"2026-08-03 20:06","pubTimestamp":1785758769,"startTime":"0","endTime":"0","summary":"Clearmind Medicine, Inc. 近日宣布,已正式签署一份意向书,计划收购一家专注于为自动泊车系统提供电动汽车无线充电解决方案的公司51%的多数股权。此举标志着该公司在清洁能源与智能交通领域的战略布局迈出关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137677655","title":"Clearmind宣佈CMND-100安全性積極成果:FDA監管臨床試驗A部分全程劑量遞增均顯示良好耐受性","url":"https://stock-news.laohu8.com/highlight/detail?id=1137677655","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137677655?lang=zh_tw&edition=fundamental","pubTime":"2026-07-30 20:31","pubTimestamp":1785414671,"startTime":"0","endTime":"0","summary":"Clearmind Medicine今日披露了其核心候选药物CMND-100的积极安全性数据。在由美国食品药品监督管理局(FDA)监管的临床试验A部分中,该药物在整个剂量递增阶段持续展现出良好的耐受性。这一结果标志着该药物在安全性评估上取得了关键进展,为后续临床开发奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199311988","title":"Clearmind Medicine公布其基於迷幻藥的神經塑形劑Meai鼻內製劑積極保留率結果","url":"https://stock-news.laohu8.com/highlight/detail?id=1199311988","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199311988?lang=zh_tw&edition=fundamental","pubTime":"2026-07-16 21:31","pubTimestamp":1784208673,"startTime":"0","endTime":"0","summary":"Clearmind Medicine报告了其基于迷幻药的神经塑形剂Meai鼻内制剂的积极保留率数据。这一结果显示了该制剂在临床研究中的良好表现,为该药物的进一步开发提供了支持。Clearmind Medicine致力于开发创新疗法,此次积极结果有望推动其神经精神疾病治疗领域的进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CMND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191574943","title":"Clearmind Medicine 就美國「大美復甦倡議」中的成癮治療創新徵詢信息作出回應","url":"https://stock-news.laohu8.com/highlight/detail?id=1191574943","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191574943?lang=zh_tw&edition=fundamental","pubTime":"2026-07-10 20:33","pubTimestamp":1783686796,"startTime":"0","endTime":"0","summary":"Clearmind Medicine, Inc. 已就美国联邦政府发布的征询信息作出正式回应。该信息征询是美国“大美复苏倡议”的一部分,旨在征集成瘾治疗领域的创新解决方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CMND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181752158","title":"Clearmind Medicine達成重大里程碑,完成FDA監管I/II期試驗A部分治療","url":"https://stock-news.laohu8.com/highlight/detail?id=1181752158","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181752158?lang=zh_tw&edition=fundamental","pubTime":"2026-06-22 20:07","pubTimestamp":1782130069,"startTime":"0","endTime":"0","summary":"Clearmind Medicine, Inc. 在药物研发道路上取得了一项关键进展,成功完成了其在美国食品药品监督管理局监管下的I/II期临床试验中的A部分治疗阶段。这标志着该公司在探索其候选药物的安全性与有效性方面迈出了坚实的一步,为其后续的临床开发计划奠定了重要基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134565904","title":"Clearmind Medicine將在「Inside Meai」網絡研討會上展示Cmnd-100迷幻藥臨床研究新發現","url":"https://stock-news.laohu8.com/highlight/detail?id=1134565904","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134565904?lang=zh_tw&edition=fundamental","pubTime":"2026-06-05 19:34","pubTimestamp":1780659246,"startTime":"0","endTime":"0","summary":"Clearmind Medicine公司计划在其“Inside Meai”网络研讨会中,重点介绍其Cmnd-100迷幻药临床研究项目的最新进展与深度见解。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CMND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172481198","title":"Clearmind Medicine宣佈約翰霍普金斯IRB批准推進CMND-100 I/II期臨床試驗進入後續階段","url":"https://stock-news.laohu8.com/highlight/detail?id=1172481198","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172481198?lang=zh_tw&edition=fundamental","pubTime":"2026-05-26 20:25","pubTimestamp":1779798321,"startTime":"0","endTime":"0","summary":"Clearmind Medicine, Inc. 宣布,其CMND-100的I/II期临床试验已获得约翰霍普金斯大学机构审查委员会的批准,得以推进至后续研究阶段。这一批准标志着该药物临床开发进程中的一个重要节点,为后续研究铺平了道路。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CMND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136197605","title":"Clearmind Medicine簽署協議,研究Meai與替爾泊肽聯用及序貫療法,挑戰GLP-1重磅藥物","url":"https://stock-news.laohu8.com/highlight/detail?id=1136197605","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136197605?lang=zh_tw&edition=fundamental","pubTime":"2026-05-18 20:42","pubTimestamp":1779108139,"startTime":"0","endTime":"0","summary":"Clearmind Medicine Inc. 已签署一项协议,旨在评估其药物Meai与替尔泊肽(Tirzepatide)联合使用及序贯治疗的潜力,以挑战当前市场上火爆的GLP-1类药物。\n该研究将深入探索Meai与替尔泊肽的协同效应,以及不同用药顺序可能带来的疗效差异。此举标志着Clearmind Medicine正积极切入巨大的代谢疾病治疗市场,直接对标已成“爆款”的GLP-1受体激动剂。\n通过这项协议,Clearmind Medicine希望为肥胖症、糖尿病等疾病的治疗提供新的、可能更具优势的联合方案。市场将密切关注其后续研究进展,看其能否在竞争激烈的GLP-1领域开辟出新路径。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131912527","title":"Clearmind Medicine首席執行官Adi Zuloff-Shani博士獲任華盛頓迷幻藥政策聯邦峯會代表","url":"https://stock-news.laohu8.com/highlight/detail?id=1131912527","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131912527?lang=zh_tw&edition=fundamental","pubTime":"2026-05-15 20:37","pubTimestamp":1778848623,"startTime":"0","endTime":"0","summary":"Clearmind Medicine首席执行官Adi Zuloff-Shani博士被任命为华盛顿特区迷幻药医学联邦政策峰会的代表。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158230672","title":"Clearmind Medicine達成重要臨床里程碑:其用於酒精使用障礙的藥物CMND-100 I/Iia期試驗現已有20名受試者接受治療","url":"https://stock-news.laohu8.com/highlight/detail?id=1158230672","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158230672?lang=zh_tw&edition=fundamental","pubTime":"2026-05-12 20:41","pubTimestamp":1778589684,"startTime":"0","endTime":"0","summary":"Clearmind Medicine, Inc. 在推进其针对酒精使用障碍的候选药物CMND-100的临床研究中,取得了一项关键进展。目前,正在进行的I/Iia期临床试验已成功为20名参与者施用了药物,这标志着该研究项目达到了一个重要的患者入组与治疗里程碑。\n这项试验旨在评估CMND-100的安全性、耐受性及初步疗效,其阶段性成果为后续研究数据的收集与分析奠定了坚实基础。公司正按计划持续推进该临床试验,以探索该创新疗法在治疗酒精使用障碍方面的潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CMND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110795205","title":"Clearmind Medicine宣佈舉辦「Inside MEAI」網絡研討會,分享CMND-100迷幻藥臨床試驗新見解","url":"https://stock-news.laohu8.com/highlight/detail?id=1110795205","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110795205?lang=zh_tw&edition=fundamental","pubTime":"2026-05-11 19:56","pubTimestamp":1778500589,"startTime":"0","endTime":"0","summary":"Clearmind Medicine, Inc. 宣布将举办一场名为“Inside MEAI”的网络研讨会。此次会议将重点展示其CMND-100迷幻药临床试验项目所取得的最新研究成果与深度见解。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131003357","title":"Clearmind Medicine提交新型迷幻化合物治療創傷後應激障礙歐洲專利申請","url":"https://stock-news.laohu8.com/highlight/detail?id=1131003357","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131003357?lang=zh_tw&edition=fundamental","pubTime":"2026-05-05 20:51","pubTimestamp":1777985481,"startTime":"0","endTime":"0","summary":"Clearmind Medicine公司近日宣布,已正式向欧洲专利局提交针对新型迷幻化合物的专利申请,该系列化合物主要用于创伤后应激障碍(PTSD)的临床治疗。此次专利布局标志着公司在精神健康治疗领域的创新研发取得重要进展。\n新型迷幻化合物通过调节神经递质系统,展现出对创伤记忆再巩固过程的独特干预能力。临床前研究表明,这类化合物能有效缓解PTSD核心症状,包括过度警觉、回避行为和侵入性记忆,同时具备较传统药物更佳的安全性特征。\n此次欧洲专利申请的提交,是继北美地区知识产权保护后,公司全球战略部署的关键一环。若获得批准,将为企业构建覆盖主要医药市场的专利护城河,为后续商业化奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CMND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106451460","title":"Clearmind Medicine Inc旗下Cmnd-100最高劑量展現卓越安全性,未出現嚴重不良事件","url":"https://stock-news.laohu8.com/highlight/detail?id=1106451460","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106451460?lang=zh_tw&edition=fundamental","pubTime":"2026-04-20 19:17","pubTimestamp":1776683836,"startTime":"0","endTime":"0","summary":"Clearmind Medicine Inc宣布,其研究药物Cmnd-100在最高剂量测试中表现出优异的安全特性,所有受试者均未出现严重不良反应。这一突破性进展为后续临床研究奠定了坚实基础,显示出该药物在安全性方面的显著优势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CMND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151385821","title":"Clearmind Medicine公布積極頂線安全性結果:CMND-100專有迷幻療法達到酒精使用障礙試驗主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=1151385821","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151385821?lang=zh_tw&edition=fundamental","pubTime":"2026-04-20 19:17","pubTimestamp":1776683831,"startTime":"0","endTime":"0","summary":"Clearmind Medicine公司宣布了其CMND-100专有迷幻疗法在酒精使用障碍临床试验中取得的积极顶线安全性结果。该试验达到了预设的主要终点,标志着公司在精神健康治疗领域取得重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186863349","title":"Clearmind Medicine公布CMND-100臨床試驗獲數據安全監查委員會積極建議","url":"https://stock-news.laohu8.com/highlight/detail?id=1186863349","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186863349?lang=zh_tw&edition=fundamental","pubTime":"2026-04-15 19:30","pubTimestamp":1776252622,"startTime":"0","endTime":"0","summary":"Clearmind Medicine Inc. (简称:Clearmind Medicine) 近日宣布,其正在进行的CMND-100临床试验获得了数据安全监查委员会的积极建议。该委员会在完成对试验数据的审阅后,建议试验按原定方案继续推进,未提出任何修改要求。这一积极评估为Clearmind Medicine的核心候选药物CMND-100的后续临床开发提供了重要支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CMND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186257826","title":"Clearmind Medicine公布第三隊列研究結果:CMND-100安全性優異,未出現嚴重不良事件","url":"https://stock-news.laohu8.com/highlight/detail?id=1186257826","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186257826?lang=zh_tw&edition=fundamental","pubTime":"2026-04-14 19:33","pubTimestamp":1776166410,"startTime":"0","endTime":"0","summary":"Clearmind Medicine Inc.最新发布的第三队列临床数据显示,其核心候选药物CMND-100展现出卓越的安全特性。研究过程中所有受试者均未报告严重不良反应,这一结果进一步强化了该药物在精神类疾病治疗领域的应用潜力。生物标志物分析表明,CMND-100的代谢途径符合预期,未出现异常药理反应。随着精神健康领域创新疗法的需求持续增长,CMND-100的阶段性成果为后续大规模临床试验奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMND","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115925857","title":"Clearmind Medicine Inc 啓動CMND-100 I/Iia期臨床試驗,評估其安全性、耐受性、藥代動力學及初步療效","url":"https://stock-news.laohu8.com/highlight/detail?id=1115925857","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115925857?lang=zh_tw&edition=fundamental","pubTime":"2026-04-14 19:33","pubTimestamp":1776166404,"startTime":"0","endTime":"0","summary":"Clearmind Medicine Inc宣布,正式开展CMND-100的I/Iia期临床试验。该研究旨在全面评估CMND-100在人体中的安全性、耐受性、药代动力学特征以及初步疗效表现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CMND"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":25,"code":"91000000","status":"200"}]}}